Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2023 Earnings Call Transcript August 9, 2023 Ionis Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.6, expectations were $-0.94. Operator: Good morning, and welcome to Ionis’ Second Quarter 2023 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn […]
Related Keywords
United States , America , Beth Hougen , National Cancer Institute On Unsplash , Astrazeneca , Life Cycle Management Program , Novartis , National Cancer Institute , Latin America , B Clear Phase ,
comparemela.com © 2020. All Rights Reserved.